Neuphoria Therapeutics Inc. (NEUP) quarterly income statement — complete revenue, gross profit & net income history
Neuphoria Therapeutics Inc. (NEUP) annual income statement — 27-year revenue, gross profit & net income history
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|
| Sales/Revenue | 1.17M | 0 | 0 | 0 | -10.47M | 25.05M | 1.07M | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 111.21% | -100% | -100% | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 165.68K | 165.69K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 14.11% | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 1.01M | -165.69K | 0 | 0 | -10.47M | 25.05M | 1.07M | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 85.89% | - | - | - | 100% | 100% | 100% | - | - | - | - | - |
| Gross Profit Growth % | 109.63% | -100.66% | -100% | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 1.17M | 1M | 6.08M | 8.55M | -91.57K | 5.06M | 6.56M | 5.25M | 8.2M | 3.69M | 6.67M | 8.54M |
| OpEx % of Revenue | 99.85% | - | - | - | 0.87% | 20.19% | 612.63% | - | - | - | - | - |
| Selling, General & Admin | 1.17M | 2.45M | 3.19M | 2.82M | -1.28M | 2.35M | 4.25M | 2.45M | 3.57M | 1.84M | 3.69M | 3.72M |
| SG&A % of Revenue | 99.85% | - | - | - | 12.2% | 9.38% | 396.73% | - | - | - | - | - |
| Research & Development | 0 | -752.55K | 1.05M | 5.73M | 700.57K | 2.7M | 2.81M | 2.8M | 4.64M | 1.85M | 2.98M | 4.82M |
| R&D % of Revenue | - | - | - | - | -6.69% | 10.77% | 262.11% | - | - | - | - | - |
| Other Operating Expenses | 0 | -694.58K | 1000K | 0 | 485.96K | 8.73K | -494.69K | 0 | -350 | 0 | 0 | 0 |
| Operating Income | -163.91K | -1.17M | -6.08M | -8.55M | -10.38M | 19.99M | -5.49M | -5.25M | -8.2M | -3.69M | -6.67M | -8.54M |
| Operating Margin % | -13.96% | - | - | - | 99.13% | 79.81% | -512.63% | - | - | - | - | - |
| Operating Income Growth % | 98.42% | -105.85% | -10.85% | -62.75% | -26.59% | 642.33% | 17.75% | 38.47% | - | - | - | - |
| EBITDA | 1.77K | -1M | -5.84M | -8.3M | -10.16M | 20.27M | -5.22M | -5.01M | -7.95M | -3.43M | -6.43M | -8.28M |
| EBITDA Margin % | 0.15% | - | - | - | 97.04% | 80.92% | -487.56% | - | - | - | - | - |
| EBITDA Growth % | 100.02% | -104.95% | -11.79% | -65.68% | -27.79% | 690.71% | 18.82% | 39.49% | - | - | - | - |
| D&A (Non-Cash Add-back) | 165.68K | 165.69K | 248.37K | 250.83K | 218.5K | 276.28K | 268.35K | 244.06K | 248.05K | 255.18K | 242.82K | 259.12K |
| EBIT | -163.91K | -1.17M | -3.51M | -8.55M | -10.38M | 19.99M | -5.49M | -5.25M | -8.2M | -3.69M | -6.53M | -8.54M |
| Net Interest Income | 170.09K | 186.17K | 167.31K | 142K | 87.05K | 12.74K | 30.61K | 36.1K | 26.33K | 52.62K | 54.72K | 86.44K |
| Interest Income | 170.09K | 186.17K | 167.31K | 142K | 87.05K | 12.74K | 30.61K | 36.1K | 26.33K | 52.62K | 54.72K | 86.44K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -4.78M | 629.38K | 8.82M | -6.49M | -4.63M | -1.32M | 2.37M | 3.87M | 4.13M | -566.29K | -53.28K | -62.09K |
| Pretax Income | -4.94M | -539.86K | 2.74M | -15.04M | -15.01M | 18.67M | -3.12M | -1.38M | -4.07M | -4.25M | -6.73M | -8.6M |
| Pretax Margin % | -420.66% | - | - | - | 143.34% | 74.54% | -291.49% | - | - | - | - | - |
| Income Tax | -34.79K | -34.79K | -52.12K | -52.64K | -156.85K | -135.59K | 18.75K | -194.69K | -51.08K | 25.23K | -50.99K | -54.34K |
| Effective Tax Rate % | 0.7% | 6.44% | -1.9% | 0.35% | 1.04% | -0.73% | -0.6% | 14.11% | 1.25% | -0.59% | 0.76% | 0.63% |
| Net Income | -4.9M | -505.06K | 2.79M | -14.99M | -14.85M | 18.81M | -3.14M | -1.19M | -4.02M | -4.28M | -6.67M | -8.55M |
| Net Margin % | -417.7% | - | - | - | 141.84% | 75.08% | -293.24% | - | - | - | - | - |
| Net Income Growth % | 66.98% | -102.69% | 188.96% | -1164.46% | -269.25% | 539.64% | 52.97% | 86.13% | - | - | - | - |
| Net Income (Continuing) | -4.9M | -505.06K | 2.79M | -14.99M | -14.85M | 18.81M | -3.14M | -1.19M | -4.02M | -4.28M | -6.67M | -8.55M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.91 | -0.09 | -0.77 | -6.67 | -6.77 | 6.55 | -0.01 | -0.00 | -29.21 | -0.02 | -0.03 | -0.04 |
| EPS Growth % | 86.56% | -101.42% | - | - | 76.83% | 33862.89% | 75% | 92.26% | - | - | - | - |
| EPS (Basic) | -0.91 | -0.09 | 0.41 | -6.67 | -6.77 | 6.55 | -0.01 | -0.00 | -29.21 | -0.02 | -0.03 | -0.04 |
| Diluted Shares Outstanding | 5.41M | 5.41M | 4.54M | 2.25M | 1.62M | 234.01M | 234.01M | 234.01M | 92M | 143.52M | 137.23M | 124.67M |
| Basic Shares Outstanding | 5.41M | 5.41M | 4.54M | 2.25M | 1.62M | 234.01M | 234.01M | 234.01M | 92M | 143.52M | 137.23M | 124.67M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |